TherapeuticsMD Ownership | Who Owns TherapeuticsMD?

Overview Forecast RevenueFinancials Chart

TherapeuticsMD Ownership Summary

TherapeuticsMD is owned by 28.12% institutional investors, 1.55% insiders, and 70.33% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 10.34% of TXMD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.16% of its assets in TherapeuticsMD shares.

TXMD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	TherapeuticsMD	28.12%	1.55%	70.33%
Sector	Healthcare Stocks	488.30%	11.08%	-399.38%
Industry	Specialty & Generic Drug Manufacturers Stocks	43.51%	11.55%	44.95%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Rubric capital management lp	1.19M	10.34%	$1.03M
Clearline capital lp	635.22K	5.49%	$736.86K
Vanguard group	387.58K	3.36%	$333.32K
Tejara capital	344.25K	2.97%	$399.33K
Adar1 capital management	209.21K	1.81%	$242.68K
Morgan stanley	131.60K	1.14%	$211.88K
Blackrock	125.15K	1.09%	$201.50K
Blackrock funding, inc. /de	116.13K	1.00%	$134.71K
Geode capital management	108.33K	0.94%	$93.20K
Bridgeway capital management	34.00K	0.29%	$29.24K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tejara capital	344.25K	0.19%	$399.33K
Adar1 capital management	209.21K	0.04%	$242.68K
Clearline capital lp	635.22K	0.03%	$736.86K
Rubric capital management lp	1.19M	0.01%	$1.03M
Two sigma securities	10.44K	0.00%	$12.11K
Bridgeway capital management	34.00K	0.00%	$29.24K
J. goldman & co lp	13.56K	0.00%	$15.73K
Tower research capital llc (trc)	4.78K	0.00%	$4.11K
Guardian wealth management	-	-	-
Blackrock	125.15K	-	$201.50K

Top Buyers

Holder	Shares	% Assets	Change
Renaissance	10.89K	-	10.89K
Tower research capital llc (trc)	4.78K	0.00%	2.51K
Group one trading	1.14K	-	1.14K
Raymond james financial	532.00	-	532.00
Bnp paribas arbitrage, snc	224.00	-	224.00

Top Sellers

Holder	Shares	% Assets	Change
Adar1 capital management	209.21K	0.04%	-60.95K
Clear harbor asset management	-	-	-25.81K
Prosperity consulting group	-	-	-24.50K
Ameriprise financial	-	-	-22.47K
Gabelli funds	-	-	-12.00K

New Positions

Holder	Shares	% Assets	Change	Value
Renaissance	10.89K	-	10.89K	$9.37K
Group one trading	1.14K	-	1.14K	$976.00K
Raymond james financial	532.00	-	532.00	$617.00
Bnp paribas arbitrage, snc	224.00	-	224.00	$193.00

Sold Out

Holder	Change
Aspire private capital	-1.00
Sterling capital management	-1.00
Northwestern mutual wealth management	-2.00
Guardian wealth management	-2.00
Qube research	-2.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	40	-2.44%	3,254,871	-2.65%	28	3.36%	10	-9.09%	9	12.50%
Mar 31, 2025	40	2.56%	3,343,569	-5.25%	28	3.09%	11	-	8	60.00%
Dec 31, 2024	24	-31.43%	1,302,899	-61.44%	11	1.32%	8	-	3	-25.00%
Sep 30, 2024	34	-8.11%	3,378,926	-0.87%	29	3.35%	8	-	4	-60.00%
Jun 30, 2024	37	-13.95%	3,408,550	0.93%	29	3.45%	8	-38.46%	10	11.11%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	249.66K	2.16%	-
Vanguard Total Stock Mkt Idx Inv	244.32K	2.11%	-5.34K
Vanguard Institutional Extnd Mkt Idx Tr	83.97K	0.73%	-38.26K
Fidelity Extended Market Index	63.62K	0.55%	-448.00
Bridgeway Ultra-Small Company Market	34.00K	0.29%	-
BlackRock Extended Equity Market K	16.29K	0.14%	-7.00
Extended Equity Market Fund K	15.80K	0.14%	-315.00
Fidelity Series Total Market Index	15.32K	0.13%	-
Fidelity Total Market Index	14.84K	0.13%	-
Spartan Extended Market Index Pool F	10.21K	0.09%	448.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 14, 2025	Thompson Tommy G	-	Buy	$325.59
Apr 14, 2025	Walker Marlan D	Chief Executive Officer	Buy	$489.27
Apr 09, 2025	Walker Marlan D	Chief Executive Officer	Buy	$993.66
Apr 10, 2025	Walker Marlan D	Chief Executive Officer	Buy	$1.00K
Aug 22, 2024	Collins Cooper C.	-	Buy	$7.10K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	4	-
2025 Q1	-	-
2024 Q3	2	-
2023 Q4	-	2
2023 Q3	-	-

TXMD Ownership FAQ

Who Owns TherapeuticsMD?

TherapeuticsMD shareholders are primarily institutional investors at 28.12%, followed by 1.55% insiders and 70.33% retail investors. The average institutional ownership in TherapeuticsMD's industry, Specialty & Generic Drug Manufacturers Stocks, is 43.51%, which TherapeuticsMD falls below.

Who owns the most shares of TherapeuticsMD?

TherapeuticsMD’s largest shareholders are Rubric capital management lp (1.19M shares, 10.34%), Clearline capital lp (635.22K shares, 5.49%), and Vanguard group (387.58K shares, 3.36%). Together, they hold 19.19% of TherapeuticsMD’s total shares outstanding.

Does Blackrock own TherapeuticsMD?

Yes, BlackRock owns 1.09% of TherapeuticsMD, totaling 125.15K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 201.5K$. In the last quarter, BlackRock decreased its holdings by -10.627K shares, a -7.83% change.

Who is TherapeuticsMD’s biggest shareholder by percentage of total assets invested?

Tejara capital is TherapeuticsMD’s biggest shareholder by percentage of total assets invested, with 0.19% of its assets in 344.25K TherapeuticsMD shares, valued at 399.34K$.

Who is the top mutual fund holder of TherapeuticsMD shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of TherapeuticsMD shares, with 2.16% of its total shares outstanding invested in 249.66K TherapeuticsMD shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools